Sirgo was one of two founders of Arius Pharmaceuticals which was merged with BDSI
in August of 2004.
Sirgo, president and Chief Executive Officer of BDSI
We are delighted to be able to commercialize the unique, patented BDSI
nanocochleate delivery technology using amphotericin B for the indication of chronic rhinosinusitis.
In its claim, originally filed in the Federal District Court of New Jersey on November 2, 2010, and formally served on BDSI
on January 19, 2011, MonoSol claims that the manufacturing process for ONSOLIS infringes its patent.
We are very pleased to have found someone of Steve's caliber with such extensive and relevant experience to join BDSI
at such an important time in the growth of the company.
approaching nearly $10 billion, we believe this represents a significant opportunity for BDSI
presentation from the Lazard Healthcare Conference will be webcast live.
As part of the EU agreement, BDSI
is entitled to receive a final milestone payment of USD2.
David Wright, Vice President of Regulatory Affairs at BDSI
Upon completion of study enrollment and database lock for each trial, and subsequently, for the acceptance of filing of the NDA by the FDA, BDSI
will receive about USD30m milestone payments from Endo.
Under the terms of its licensing agreement with Meda, BDSI
receives a milestone payment of $2.
The agreement results in potential milestone payments to BDSI
of up to $1,300,000, which includes an upfront payment of $300,000.